How Do Emerging Adults (EAs) with Type 1 Diabetes (T1D) Seek Self-Care Information?DIABETESIF7.52024-06-140PRE
Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasmsHAEMATOLOGICAIF7.92019-08-140OAAI
Assessment of Parental Preparedness for Transition of Their Child's Diabetes Care from Pediatric to Adult ProvidersDIABETESIF7.52019-06-010PRE
Developing a Professional Identity as a Change Agent Early in Medical School: the Students' VoiceJOURNAL OF GENERAL INTERNAL MEDICINEIF4.22019-02-1917OAAI
EDUCATING MEDICAL STUDENTS ABOUT TRANSITION FROM PEDIATRIC TO ADULT CARE: STUDENT PERSPECTIVESJOURNAL OF ADOLESCENT HEALTHIF4.52019-02-010OAAI
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition (vol 128, pg 789 2018)JOURNAL OF CLINICAL INVESTIGATIONIF13.62018-09-176OA
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibitionJOURNAL OF CLINICAL INVESTIGATIONIF13.62018-01-2263OAAI
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid LeukemiaCANCER DISCOVERYIF33.32017-04-30103OAAI
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingNATURE MEDICINEIF502016-11-14213OAAI
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cellsLEUKEMIAIF13.42015-12-2965OAAI
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesisJOURNAL OF EXPERIMENTAL MEDICINEIF10.62015-10-05136OAAI
Leukemia-associated DNMT3A R882 mutations and their role in anthracycline-induced DNA damage response and therapeutic resistanceCANCER RESEARCHIF16.62014-12-120PRE